EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Efficacy and Safety of Ab Externo Open Conjunctiva XEN® 63 µm Implantation with a 30G Needle Scleral Tract in Primary Open-Angle Glaucoma

Yann Bertolani iD, Jaume Rigo-Quera, Laura Sánchez-Vela, Olivia Pujol-Carreras, Manuel Amilburu, Antonio Dou, Marta Castany

Journal of Clinical Medicine · 05.05.2025 · 14 (9) · 3195

DOI: 10.3390/jcm14093195 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 05.05.2025. Verfasst von Yann Bertolani und 6 weiteren Autor:innen. Beteiligte Einrichtung: Ophthalmology, Vall d'Hebron University Hospital, 08035 Barcelona, Spain. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This study aimed to assess the efficacy and safety of the 30G needle mediated ab externo open conjunctiva approach for the XEN 63 µm implant in primary open-angle glaucoma.

Methods

A retrospective and non-randomized study was conducted on consecutive cases of medically refractory primary open-angle glaucoma treated with standalone ab externo open conjunctiva XEN® 63 µm (North Chicago, Illinois) with one-year follow-up.

Results

Twenty-two eyes were included. The mean preoperative intraocular pressure was 21.9 ± 7.2 mmHg, and the mean number of glaucoma medications was 2.4 ± 0.9. All patients underwent mitomycin 0.02% application for 2 min, and Healaflow® (MedicalMix, Spain), was implanted in 11 cases (50%). Complete surgical success was achieved in 14 cases (63.6%). No statistical differences in complete surgical success were noted based on the use of Healaflow®. A significant reduction in intraocular pressure (11.8 ± 3.4 mmHg) and in the number of hypotensive medications (0.2 ± 0.5 mmHg) was observed 1 year after the procedure. Transient hypotony was detected in 31.8% of cases. Complications secondary to hypotony included four cases of serous choroidal detachment and one case of localized hemorrhagic choroidal detachment, the latter associated with hypotonic keratopathy and hypotonic maculopathy. All these complications evolved favorably with conservative management and adjusted topical treatment.

Conclusions

This study highlights the efficacy and safety of this approach for the XEN 63 µm implant in medically refractory primary open-angle glaucoma.

Schlagwörter

Stichwörter der Autor:innen

XEN63 µmintraocular surgeryminimally invasive glaucoma surgeryopen conjunctiva approachprimary open-angle glaucomasurvival analysis

Autor:innen und Institutionen

  • Ophthalmology, Vall d'Hebron University Hospital, 08035 Barcelona, Spain.

ORCID-Profile: Yann Bertolani

Zitieren

APA

Bertolani, Y., Rigo-Quera, J., Sánchez-Vela, L., Pujol-Carreras, O., Amilburu, M., Dou, A., & Castany, M. (2025). Efficacy and Safety of Ab Externo Open Conjunctiva XEN® 63 µm Implantation with a 30G Needle Scleral Tract in Primary Open-Angle Glaucoma. Journal of Clinical Medicine, 14(9), 3195. https://doi.org/10.3390/jcm14093195

Vancouver

Bertolani Y, Rigo-Quera J, Sánchez-Vela L, Pujol-Carreras O, Amilburu M, Dou A, et al. Efficacy and Safety of Ab Externo Open Conjunctiva XEN® 63 µm Implantation with a 30G Needle Scleral Tract in Primary Open-Angle Glaucoma. Journal of Clinical Medicine. 2025;14(9):3195. doi:10.3390/jcm14093195

BibTeX
@article{Bertolani2025,
  author = {Bertolani, Yann and Rigo-Quera, Jaume and Sánchez-Vela, Laura and Pujol-Carreras, Olivia and Amilburu, Manuel and Dou, Antonio and Castany, Marta},
  title = {Efficacy and Safety of Ab Externo Open Conjunctiva XEN® 63 µm Implantation with a 30G Needle Scleral Tract in Primary Open-Angle Glaucoma},
  journal = {Journal of Clinical Medicine},
  year = {2025},
  volume = {14},
  number = {9},
  pages = {3195},
  doi = {10.3390/jcm14093195}
}
Kostenlos starten →